Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 1
2005 3
2006 3
2007 1
2008 2
2010 3
2011 2
2012 2
2014 2
2015 1
2016 1
2017 1
2018 3
2019 3
2020 8
2021 1
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells.
Bevers S, Kooijmans SAA, Van de Velde E, Evers MJW, Seghers S, Gitz-Francois JJJM, van Kronenburg NCH, Fens MHAM, Mastrobattista E, Hassler L, Sork H, Lehto T, Ahmed KE, El Andaloussi S, Fiedler K, Breckpot K, Maes M, Van Hoorick D, Bastogne T, Schiffelers RM, De Koker S. Bevers S, et al. Among authors: fens mham. Mol Ther. 2022 Sep 7;30(9):3078-3094. doi: 10.1016/j.ymthe.2022.07.007. Epub 2022 Jul 12. Mol Ther. 2022. PMID: 35821637 Free PMC article.
Levodopa-loaded nanoparticles for the treatment of Parkinson's disease.
van Vliet EF, Knol MJ, Schiffelers RM, Caiazzo M, Fens MHAM. van Vliet EF, et al. Among authors: fens mham. J Control Release. 2023 Aug;360:212-224. doi: 10.1016/j.jconrel.2023.06.026. Epub 2023 Jun 24. J Control Release. 2023. PMID: 37343725 Free article. Review.
Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progression.
Ecker V, Brandmeier L, Stumpf M, Giansanti P, Moreira AV, Pfeuffer L, Fens MHAM, Lu J, Kuster B, Engleitner T, Heidegger S, Rad R, Ringshausen I, Zenz T, Wendtner CM, Müschen M, Jellusova J, Ruland J, Buchner M. Ecker V, et al. Among authors: fens mham. Cell Rep. 2023 Oct 31;42(10):113017. doi: 10.1016/j.celrep.2023.113017. Epub 2023 Oct 4. Cell Rep. 2023. PMID: 37792532 Free article.
Red Blood Cells: Chasing Interactions.
Pretini V, Koenen MH, Kaestner L, Fens MHAM, Schiffelers RM, Bartels M, Van Wijk R. Pretini V, et al. Among authors: fens mham. Front Physiol. 2019 Jul 31;10:945. doi: 10.3389/fphys.2019.00945. eCollection 2019. Front Physiol. 2019. PMID: 31417415 Free PMC article. Review.
Nanomedicines for the treatment of hematological malignancies.
Deshantri AK, Varela Moreira A, Ecker V, Mandhane SN, Schiffelers RM, Buchner M, Fens MHAM. Deshantri AK, et al. Among authors: fens mham. J Control Release. 2018 Oct 10;287:194-215. doi: 10.1016/j.jconrel.2018.08.034. Epub 2018 Aug 28. J Control Release. 2018. PMID: 30165140 Review.
Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles.
Swart LE, Fens MHAM, van Oort A, Waranecki P, Mata Casimiro LD, Tuk D, Hendriksen M, van den Brink L, Schweighart E, Seinen C, Nelson R, Krippner-Heidenreich A, O'Toole T, Schiffelers RM, Kooijmans S, Heidenreich O. Swart LE, et al. Among authors: fens mham. Pharmaceutics. 2023 May 27;15(6):1603. doi: 10.3390/pharmaceutics15061603. Pharmaceutics. 2023. PMID: 37376052 Free PMC article.
Development and characterization of liposomal formulation of bortezomib.
Deshantri AK, Metselaar JM, Zagkou S, Storm G, Mandhane SN, Fens MHAM, Schiffelers RM. Deshantri AK, et al. Among authors: fens mham. Int J Pharm X. 2019 Mar 23;1:100011. doi: 10.1016/j.ijpx.2019.100011. eCollection 2019 Dec. Int J Pharm X. 2019. PMID: 31517276 Free PMC article.
44 results